This is an NIH/NCI research grant (U01) for studies that use the PLCO cancer screening trial biospecimens to advance cancer etiology and early detection biomarker research. It fits labs, universities, biotech firms, and research organizations that can design a project around these specific samples. Businesses with no cancer research or biospecimen capability should not bother applying.
| Industry | Estimated fit |
|---|---|
| Healthcare & BiotechMatches your industry (clinical) | 75 |
| Agriculture & FarmingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Arts & CultureLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Education & TrainingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech | 54 |
| Environment & ConservationLimit: Nothing in this notice points to environment & conservation | 54 |
| Industry | Estimated fit |
|---|---|
| Finance & BankingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Food & BeverageLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Housing & Real EstateLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| ManufacturingLimit: Nothing in this notice points to manufacturing | 54 |
| Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce | 54 |
| Social Services & NonprofitLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Technology & SoftwareLimit: Nothing in this notice points to technology & software | 54 |
| Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics | 53 |
| Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure | 50 |
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.
NIH/NCI U01 research grants using the PLCO cancer screening trial biospecimens to study cancer etiology and early detection biomarkers. Open to small businesses, for-profits, nonprofits, universities, and state/local/tribal governments; projects must use PLCO biospecimens.
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Topics
Open opportunities funding similar work, from the same funder or in the same place.
NIH BRAIN Initiative grants to develop tools and computational models for high-resolution, synchronous measurement of complex behaviors alongside neural activity in humans and other species. Eligible applicants include…
NIH/NCI K99/R00 career-development award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent tenure-track faculty positions; requires the candidate to lead an…
NIH/NCI UH3 cooperative agreement to clinically validate established molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, or treatment response using specimens from…
NIH/NCI K99/R00 award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent faculty careers. The applicant is typically the sponsoring institution; eligible…
NIH/NCI cooperative agreement (UH2/UH3) funding validation of molecular, cellular, and imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Open to universities,…
NIH/NCI program funding revision applications to adapt and clinically validate molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction.…